Synnovation Therapeutics, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.synnovationtx.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (100.0%)SNV4818 in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- Pikavation Therapeutics, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06736704
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
πΊπΈThomas Jefferson University-Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
πΊπΈSarah Cannon Research Institute, Nashville, Tennessee, United States
SNV1521 in Participants with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Synnovation Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06220864
- Locations
- πΊπΈ
Yale University, New Haven, Connecticut, United States
πΊπΈThomas Jefferson University, Philadelphia, Pennsylvania, United States
π¦πΊPrincess Alexandra Hospital, Woolloongabba, Queensland, Australia
News
No news found